Continue to Site

Endress+Hauser invests $4.5 million in U.S. sales and service support

By Brian Buntz | January 6, 2021

Endress Reinach, Switzerland-based Endress+Hauser, announced a new plan to beef up support of its U.S. operations with a $4.5 million investment.

The funding will enable the company to expand its project management, application engineering, services and other offerings.

“We will have more people in field assisting our customers’ needs,” said Todd Lucey, a general manager at Endress+Hauser USA in a statement.

The company offers automation technology and services to the pharmaceutical and chemical sectors, among others.

In general, COVID-19 has been a driver of automation and robotics adoption as many industrial companies grapple with social-distancing restrictions and seek to improve their resilience.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.